The frequency of TP53 mutations also remains largely unknown in the Chinese population, therefore, our study aims to investigate the prevalence of TP53 mutation in Chinese breast cancer patients and unravel the clinical characteristics of TP53 mutations in their families. Here, TP53 is linked to breast carcinoma.